SCHEMBL20023311

SCHEMBL20023311

CC1(C)c2ccccc2-c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc5c(c4)-c4c(ccc6oc7ccccc7c46)C5(C)C)cc3)cc21

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.33
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
ALK Q9UM73 2/20 0.31
WEE1 P30291 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20023310 0.97 PDK2 (0.33) PDK2PLA2G2APLA2G4AALKWEE1
SCHEMBL23743420 0.94 ALK (0.31) ALKWEE1
SCHEMBL23743461 0.94 ALK (0.32) PLA2G2APLA2G4AALKWEE1
SCHEMBL21791163 0.93 WEE1 (0.34) PLA2G2APLA2G4AALKWEE1
SCHEMBL20023544 0.92 PDK2 (0.32) PDK2PLA2G2APLA2G4AALK
SCHEMBL20828567 0.91 MAPT (0.31) PDK2ALKWEE1
SCHEMBL22389237 0.91 ALK (0.32) PLA2G2APLA2G4AALKWEE1
SCHEMBL24531489 0.91 PDK2 (0.31) PDK2
SCHEMBL20828572 0.90 ALK (0.32) PLA2G2APLA2G4AALKWEE1
SCHEMBL20023314 0.90 ALK (0.33) PLA2G2APLA2G4AALKWEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305782-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME SFC Co., Ltd. (KR) 2018-04-11 EP disclosed
US-20180093962-A1 NOVEL ORGANIC COMPOUND AND ORANIC LIGHT-EMITTING DIODE COMPRISING SAME BACKGROUND OF THE INVENTION SFC CO., LTD. (KR) 2018-04-05 US disclosed
US-20180093962-A1 NOVEL ORGANIC COMPOUND AND ORANIC LIGHT-EMITTING DIODE COMPRISING SAME BACKGROUND OF THE INVENTION SFC CO., LTD. (KR) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093962-A1 NOVEL ORGANIC COMPOUND AND ORANIC LIGHT-EMITTING DIODE COMPRISING SAME BACKGROUND OF THE INVENTION ORC3, OR10J3, OR51E2 PDK2 992/4885PLA2G2A 3665/4885PLA2G4A 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.